Cerebrum Matter

Curated by Signal

Provider of diagnostic platform for neuro-degenerative disorders

Overview

Cerebrum Matter provides a diagnostic platform for neuro-degenerative disorders like dementia, Alzheimers and more. The company develops a platform COSMA, which is a personalized brain training software helps in analyzing the cognitive activity of the elder patient's neuro-activity via the headset worn during the play. The hardware device gives clinical insights and feedback on the patient's neurological activity for the early diagnosis and prevention of dementia.

Key facts

Founded: 2015
Headquarters: Loughborough, United Kingdom
Stage: Sign up to view
Industry: Health Technology

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Stable Innovations
Developer of wearable fitness tracker for horses
Health TechnologyDownpatrick, United Kingdom
Alterola Biotech
Developer of cannabis-derived therapeutics for multiple indications
Health TechnologyBirkenhead, United Kingdom
GW Pharma
Developer of cannabinoid medicines for MS spasticity, cancer pain and childhood epilepsy
Health TechnologyCambridge, United Kingdom

About Cerebrum Matter

What does Cerebrum Matter do?

Cerebrum Matter provides a diagnostic platform for neuro-degenerative disorders like dementia, Alzheimers and more.

Where is Cerebrum Matter headquartered?

Cerebrum Matter is headquartered in Loughborough, United Kingdom.

When was Cerebrum Matter founded?

Cerebrum Matter was founded in 2015.

Which sector is Cerebrum Matter in?

Cerebrum Matter operates in Health Technology.

Who are Cerebrum Matter's competitors?

Companies similar to Cerebrum Matter include Stable Innovations, Alterola Biotech, and GW Pharma.